SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)	3 Months Ended			6 Months Ended	9 Months Ended		12 Months Ended
	Sep. 30, 2017	Mar. 31, 2017	Sep. 30, 2016	Jun. 30, 2017	Sep. 30, 2017	Sep. 30, 2016	Dec. 31, 2016	Sep. 30, 2017	Jan. 09, 2017	Dec. 31, 2016	Dec. 31, 2008
Revenue Recognition [Abstract]
Deferred revenue								$ 0		$ 392,517
Inventories [Abstract]
Raw materials								2,339,615		1,824,248
Work in process								413,800		535,320
Finished goods								2,481,749		975,620
Inventories								5,235,164		3,335,188
Inventory valuation reserves			$ 245,000			$ 245,000
Summary of weighted average shares used for computation of basic and diluted earnings per share [Abstract]
Basic (in shares)	12,311,098		11,142,090		12,293,781	10,150,737
Diluted (in shares)	12,311,098		11,142,090		12,293,781	10,150,737
Summary of common share equivalent basis, used in diluted per share computations [Abstract]
Additional stock options (in shares)	0
Options and warrants excluded from calculation of diluted per common share equivalent because the effect would have been anti-dilutive (in shares)	699,663		614,949		668,510	677,050
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of stock options exercised under the plan (in shares)	46,000	10,969					191,804
Weighted average estimated grant-date fair value of stock options granted (in dollars per share)					$ 2.22	$ 2.77
Stock options, number of shares [Roll forward]
Exercised (in shares)	46,000	10,969					191,804
Stock options, outstanding, weighted average exercise price per share [Roll Forward]
Exercised (in dollars per share)	$ 4.24	$ 4.19
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Allocated share-based compensation expense	$ 87,100		$ 74,100		$ 296,700	$ 220,300
Revenues from External Customers [Line Items]
Net product sales	$ 6,132,725		$ 2,502,097		$ 14,453,097	$ 10,453,188
Summary of accounts payable and accrued liabilities [Abstract]
Accounts payable - suppliers								2,352,192		1,437,290
Accrued commissions								339,380		221,982
Accrued royalties / license fees								219,505		352,660
Accrued payroll								248,563		167,575
Accrued vacation								313,490		289,587
Accrued bonuses								0		282,500
Accrued expenses - other								397,031		261,539
TOTAL								$ 3,870,161		$ 3,013,133
Minimum [Member]
Stock options, outstanding, weighted average exercise price per share [Roll Forward]
Exercised (in dollars per share)							$ 2.80
Maximum [Member]
Stock options, outstanding, weighted average exercise price per share [Roll Forward]
Exercised (in dollars per share)							$ 5.56
Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of stock options outstanding under the plan (in shares)	685,670	600,549			600,549		600,549	685,670		600,549
Number of stock options exercised under the plan (in shares)					56,969
Assumptions made in calculating fair values of options [Abstract]
Expected term	4 years 6 months		0 years		4 years 9 months 18 days
Expected volatility	41.22%		0.00%		43.01%
Expected dividend yield	0.00%		0.00%		0.00%	0.00%
Risk-free interest rate	1.48%		0.00%		1.54%
Stock options, number of shares [Roll forward]
Outstanding, beginning of period (in shares)		600,549			600,549
Granted (in shares)					142,875		106,875
Exercised (in shares)					56,969
Forfeited/expired/cancelled (in shares)					785
Outstanding, end of period (in shares)	685,670				685,670		600,549
Exercisable, end of period (in shares)	347,295				347,295
Stock options, outstanding, weighted average exercise price per share [Roll Forward]
Outstanding, beginning of period (in dollars per share)		$ 4.55			$ 4.55
Granted (in dollars per share)					5.84
Exercised (in dollars per share)					4.19
Forfeited/expired/cancelled (in dollars per share)					5.56
Outstanding, end of period (in dollars per share)	$ 4.84				4.84		$ 4.55
Exercisable, end of period (in dollars per share)	$ 4.34				$ 4.34
Stock options, additional disclosure [Abstract]
Outstanding, weighted average remaining contractual term					3 years 4 months 6 days		3 years 5 months 5 days
Exercisable, weighted average remaining contractual term					2 years 10 months 6 days
Outstanding, aggregate intrinsic value, beginning of period		$ 1,463,052			$ 1,463,052
Exercised, aggregate intrinsic value					34,152
Outstanding, aggregate intrinsic value, end of period	$ 1,092,813				1,092,813		$ 1,463,052
Exercisable, aggregate intrinsic value, end of period	$ 693,550				$ 693,550
Net unrecognized compensation cost								$ 387,192
Weighted average period for recognition of net unrecognized compensation cost					2 years 4 months 2 days
Total fair value of stock options vested during period					$ 323,113	$ 237,095
Stock Options [Member] | Minimum [Member]
Assumptions made in calculating fair values of options [Abstract]
Expected term						4 years 9 months 18 days
Expected volatility						46.18%
Risk-free interest rate						0.93%
2008 Stock Incentive Plan [Member] | Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares authorized under the plan (in shares)								750,000			625,000
Number of stock options outstanding under the plan (in shares)	228,177				228,177			228,177
Increase in number of shares authorized (in shares)					125,000
Number of stock options exercised under the plan (in shares)					480,172
Stock options, number of shares [Roll forward]
Exercised (in shares)					480,172
Outstanding, end of period (in shares)	228,177				228,177
2014 Stock Incentive Plan [Member] | Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares authorized under the plan (in shares)								800,000
Number of stock options outstanding under the plan (in shares)	250,625				250,625			250,625
Number of stock options exercised under the plan (in shares)					22,000
Options or shares still available to be issued (in shares)								527,375
Stock options, number of shares [Roll forward]
Exercised (in shares)					22,000
Outstanding, end of period (in shares)	250,625				250,625
Cost of Goods Sold [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Allocated share-based compensation expense	$ 12,800		$ 0		$ 34,200	$ 0
Research and Development Expense [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Allocated share-based compensation expense	12,100		27,300		77,300	62,000
Selling, General and Administrative Expenses [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Allocated share-based compensation expense	62,200		46,800		185,200	158,300
Africa [Member]
Revenues from External Customers [Line Items]
Net product sales	965,606		577,108		1,797,285	1,686,327
Asia [Member]
Revenues from External Customers [Line Items]
Net product sales	93,101		34,116		1,637,065	187,105
Europe [Member]
Revenues from External Customers [Line Items]
Net product sales	401,730		313,664		1,441,890	642,427
North America [Member]
Revenues from External Customers [Line Items]
Net product sales	1,115,473		903,327		2,874,934	3,953,469
South America [Member]
Revenues from External Customers [Line Items]
Net product sales	$ 3,556,815		$ 673,882		$ 6,701,923	$ 3,983,860
RVR Diagnostics Sdn Bhd [Member]
Intangible assets [Abstract]
Intangible assets									$ 1,800,000
Amortization of intangible assets				$ 339,000